SARS-CoV-2 Variants and COVID-19 in Bangladesh-Lessons Learned

被引：0

作者：

Lytton, Simon D. ^{[1
]}

Ghosh, Asish Kumar ^{[2
]}

机构：

[1] SeraDiaLogistics, D-81545 Munich, Germany

[2] Dhaka Med Coll Hosp, Dept Virol, Dhaka 1000, Bangladesh

来源：

VIRUSES-BASEL | 2024年 / 16卷 / 07期

关键词：

Bangladesh; COVID-19; SARS-CoV-2; variants; vaccination coverage; pandemic preparedness; IMMUNE ESCAPE; CHALLENGES;

D O I：

10.3390/v16071077

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The coronavirus infectious disease-2019 (COVID-19) in Bangladesh is a paradigm for how one of the most densely populated countries in the world, with 1270 people per square kilometer, managed to cope with the COVID-19 pandemic under extraordinary circumstances. This review highlights the SARS-CoV-2 variants in Bangladesh and the timeline of their detection in the context of the global experience with the management of vaccination and natural SARS-CoV-2 infection. The motivation to overcome the COVID-19 vaccine dilemma and track Bangladeshi SARS-CoV-2 sub-variants underscores the potential for a low-income country to excel in international medical science, despite having stressed health care services and limited availability of resources for SARS-CoV-2 testing and gene sequencing.

引用

页数：15

共 50 条

[1] SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
Dao, Thi Loi
Hoang, Van Thuan
Colson, Philippe
Lagier, Jean Christophe
Million, Matthieu
Raoult, Didier
Levasseur, Anthony
Gautret, Philippe
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
[2] Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants
Pagliano, Pasquale
Spera, Annamaria
Sellitto, Carmine
Scarpati, Giuliana
Folliero, Veronica
Piazza, Ornella
Franci, Gianluigi
Conti, Valeria
Ascione, Tiziana
EXPERT OPINION ON DRUG DISCOVERY, 2023, : 1301 - 1311
[3] Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants
Pagliano, Pasquale
Spera, Annamaria
Sellitto, Carmine
Scarpati, Giuliana
Folliero, Veronica
Piazza, Ornella
Franci, Gianluigi
Conti, Valeria
Ascione, Tiziana
EXPERT OPINION ON DRUG DISCOVERY, 2023,
[4] Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou, Zhou
Zhu, Yimiao
Chu, Ming
FRONTIERS IN IMMUNOLOGY, 2022, 13
[5] Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Firouzabadi, Negar
Ghasemiyeh, Parisa
Moradishooli, Fatemeh
Mohammadi-Samani, Soliman
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 117
[6] Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination
Bbosa, Nicholas
Kiiza, Ronald
Ssekagiri, Alfred
Namagembe, Hamidah Suubi
Nabirye, Stella Esther
Kabuuka, Danstan
Rwankindo, Cleophous
Kisakye, Annet
Woldemariam, Yonas T.
Kusemererwa, Sylvia
Ongaria, Terry A.
Kakande, Ayoub
Abaasa, Andrew
Kimbugwe, Geofrey
Bosa, Henry Kyobe
Driwale, Alfred
Mwenda, Jason M.
Worwui, Archibald K.
Humphreys, James
Cohuet, Sandra
Elliott, Alison M.
Ruzagira, Eugene
Kaleebu, Pontiano
Ssemwanga, Deogratius
VIRUSES-BASEL, 2024, 16 (12):
[7] SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
Liang, Hong-Yu
Wu, Yuyan
Yau, Vicky
Yin, Huan-Xin
Lowe, Scott
Bentley, Rachel
Ahmed, Mubashir Ayaz
Zhao, Wenjing
Sun, Chenyu
VACCINES, 2022, 10 (09)
[8] COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants
Stefanelli, Paola
Rezza, Giovanni
VACCINES, 2022, 10 (06)
[9] An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
Hillary, Varghese Edwin
Ceasar, Stanislaus Antony
HELIYON, 2023, 9 (03)
[10] Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19
Ramos, A. M.
Vela-Perez, M.
Ferrandez, M. R.
Kubik, A. B.
Ivorra, B.
COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION, 2021, 102

← 1 2 3 4 5 →